Combination of IGF1R/FAK inhibition and PI3K/mTOR inhibition in triple-negative breast cancers

被引：0
|
作者：
Taliaferro-Smith, LaTonia D. [1 ]
Liu, Tongrui [1 ]
Alcaide, Tiffanie Y. [1 ]
McGlothen, Tanisha Z. [1 ]
O'Regan, Ruth M. [1 ]
机构：
[1] Emory Univ, Winship Canc Inst, Atlanta, GA 30322 USA
来源：
CANCER RESEARCH | 2015年 / 75卷
关键词：
D O I：
10.1158/1538-7445.SABCS14-P5-07-07
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P5-07-07
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Sensitization of triple-negative breast cancer to PI3K inhibition by cotargeting IGF1R
    de Lint, K.
    Poell, J. B.
    Rodriguez, J. Vidal
    Soueidan, H.
    Nijkamp, W.
    Wessels, L. F.
    Beijersbergen, R. L.
    [J]. EUROPEAN JOURNAL OF CANCER, 2014, 50 : 31 - 31
  • [2] Sensitizing Triple-Negative Breast Cancer to PI3K Inhibition by Cotargeting IGF1R
    de Lint, Klaas
    Poell, Jos B.
    Soueidan, Hayssam
    Jastrzebski, Katarzyna
    Rodriguez, Jordi Vidal
    Lieftink, Cor
    Wessels, Lodewyk F. A.
    Beijersbergen, Roderick L.
    [J]. MOLECULAR CANCER THERAPEUTICS, 2016, 15 (07) : 1545 - 1556
  • [3] Combination of insulin-like growth factor 1 receptor and PI3K/mTOR inhibition in triple-negative breast cancers
    Liu, T.
    Taliaferro-Smith, L. D.
    O'Regan, R.
    [J]. CANCER RESEARCH, 2013, 73
  • [4] COMBINED IGF1R AND FAK INHIBITION AS A POTENTIAL THERAPEUTIC OPTION IN TRIPLE NEGATIVE BREAST CANCER
    MacMahon, D.
    Zhou, Z.
    Alcaide, T.
    Liu, T.
    McGlothen
    Taliaferro-Smith, L.
    O'Regan, R.
    [J]. IRISH JOURNAL OF MEDICAL SCIENCE, 2014, 183 : S545 - +
  • [5] Dual PI3K and Wnt pathway inhibition is a synergistic combination against triple-negative breast cancer
    Solzak, Jeffrey P.
    Atale, Rutuja
    Hancock, Brad
    Radovich, Milan
    [J]. CANCER RESEARCH, 2015, 75
  • [6] Role of PTEN, PI3K, and mTOR in Triple-Negative Breast Cancer
    Prvanovic, Mirjana
    Nedeljkovic, Milica
    Tanic, Nasta
    Tomic, Tijana
    Terzic, Tanja
    Milovanovic, Zorka
    Maksimovic, Zlatko
    Tanic, Nikola
    [J]. LIFE-BASEL, 2021, 11 (11):
  • [7] Activation of IGF1R/p110β/AKT/mTOR confers resistance to α-specific PI3K inhibition
    Cedric Leroy
    Pedro Ramos
    Karen Cornille
    Debora Bonenfant
    Christine Fritsch
    Hans Voshol
    Mohamed Bentires-Alj
    [J]. Breast Cancer Research, 18
  • [8] Activation of IGF1R/p110β/AKT/mTOR confers resistance to α-specific PI3K inhibition
    Leroy, Cedric
    Ramos, Pedro
    Cornille, Karen
    Bonenfant, Debora
    Fritsch, Christine
    Voshol, Hans
    Bentires-Alj, Mohamed
    [J]. BREAST CANCER RESEARCH, 2016, 18
  • [9] Combined PI3K and AURKA inhibition are efficacious in triple-negative breast cancer models
    Van Swearingen, Amanda E. D.
    Sambade, Maria J.
    Sud, Shivani
    Golitz, Brian
    Johnson, Gary L.
    Anders, Carey K.
    [J]. CANCER RESEARCH, 2016, 76
  • [10] Myricetin-induced apoptosis in triple-negative breast cancer cells through inhibition of the PI3K/Akt/mTOR pathway
    Sharma, Preeti
    Khan, Mohammad Ahmed
    Najmi, Abul Kalam
    Chaturvedi, Shubhra
    Akhtar, Mohd
    [J]. MEDICAL ONCOLOGY, 2022, 39 (12)
12345